Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. 2023
  2. Published

    Endotrophin as a risk marker of mortality and kidney complications in a type 1 diabetes cohort

    Møller, A. L., Tougaard, N. H., Rasmussen, D. G. K., Genovese, F., Rønn, P. F., Hansen, T. W., Karsdal, M. A. & Rossing, Peter, 2023, In: Frontiers in Molecular Biosciences. 10, 1229579.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes

    Rossing, Peter, Groehl, F., Mernagh, P., Folkerts, K., Garreta-Rufas, A., Harris, J., Meredith, K., Carter, M., Åkerborg, Ö., Wanner, C. & Hobbs, F. D. R., 2023, In: Journal of Medical Economics. 26, 1, p. 935-943 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Evaluation of the effects of ezetimibe on albuminuria and kidney fat in individuals with type 2 diabetes and chronic kidney disease

    Heinrich, N. S., Pedersen, R. P., Vestergaard, M. B., Lindberg, U., Andersen, U. B., Haddock, B., Hansen, T. W., Fornoni, A., Larsson, Henrik Bo Wiberg & Rossing, Peter, 2023, In: Diabetes, Obesity and Metabolism. 25, 9, p. 2605-2615 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis

    McEwan, P., Boyce, R., Sanchez, J. J. G., Sjöström, C. D., Stefansson, B., Nolan, S., Correa-Rotter, R., Rossing, Peter, Chertow, G. M., McMurray, J. J. V., Wheeler, D. C. & Heerspink, H. J. L., 2023, In: Nephrology Dialysis Transplantation. 38, 5, p. 1260-1270 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis

    Filippatos, G., Anker, S. D., August, P., Coats, A. J. S., Januzzi, J. L., Mankovsky, B., Rossing, Peter, Ruilope, L. M., Pitt, B., Sarafidis, P., Teerlink, J. R., Kapelios, C. J., Gebel, M., Brinker, M., Joseph, A., Lage, A., Bakris, G. & Agarwal, R., 2023, In: European heart journal. Cardiovascular pharmacotherapy. 9, 2, p. 183-191 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease

    Filippatos, G., Anker, S. D., Pitt, B., McGuire, D. K., Rossing, Peter, Ruilope, L. M., Butler, J., Jankowska, E. A., Michos, E. D., Farmakis, D., Farjat, A. E., Kolkhof, P., Scalise, A., Joseph, A., Bakris, G. L. & Agarwal, R., 2023, In: European heart journal. Cardiovascular pharmacotherapy. 9, 1, p. 85-93 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials

    Flack, J. M., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Rossing, Peter, Adler, S. G., Fried, L., Jamerson, K., Toto, R., Brinker, M., Farjat, A. E., Kolkhof, P., Lawatscheck, R., Joseph, A., Bakris, G. L. & FIDELIO-DKD and FIGARO-DKD Investigators, F. A. F. I., 2023, In: Kidney Medicine. 5, 12, 11 p., 100730.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis

    Rosas, S. E., Ruilope, L. M., Anker, S. D., Pitt, B., Rossing, Peter, Bonfanti, A. A. C., Correa-Rotter, R., González, F., Munoz, C. F. J., Pergola, P., Umpierrez, G. E., Scalise, A., Scott, C., Lawatscheck, R., Joseph, A., Bakris, G. L. & FIDELIO-DKD and FIGARO-DKD Investigators, F. A. F. I., 2023, In: Kidney Medicine. 5, 10, 10 p., 100704.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use

    the FIDELIO-DKD and FIGARO-DKD investigators, T. F. A. F. I., 2023, In: Diabetes, Obesity and Metabolism. 25, 2, p. 407-416 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Four missense genetic variants in CUBN are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in Europeans

    Uglebjerg, N., Ahmadizar, F., Aly, D. M., Cañadas-Garre, M., Hill, C., Naber, A., Oddsson, A., Singh, S. S., Smyth, L., Trégouët, D. A., Chaker, L., Ghanbari, M., Steinthorsdottir, V., Ahlqvist, E., Hadjadj, S., Van Hoek, M., Kavousi, M., McKnight, A. J., Sijbrands, E. J., Stefansson, K. & 3 others, Simons, M., Rossing, Peter & Ahluwalia, T. S., 2023, In: Frontiers in Endocrinology. 14, 11 p., 1081741.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...3 4 5 6 7 8 9 10 ...51 Next

ID: 12937790